Developing a robust long-term portfolio, licensing & development strategy is paramount for life sciences companies seeking to gain a competitive advantage in an industry where new innovations and breakthroughs seem to be on the constant horizon. Putnam brings a unique blend of clinical and scientific expertise, innovative business strategy and over three decades of strategic experience to advise on optimal and sustainable portfolio, licensing and development strategies for life sciences clients across the globe.
- Long term portfolio planning and optimization
- Therapeutic area landscape evolution analysis planning
- Technology & asset scans
- In-licensing/out-licensing due diligence
- Integrative strategy development that incorporates both legacy and newly acquired assets